SEC Form 4 · accession 0001437749-26-019883
Electromed, Inc. · ELMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradley M. Nagel
Officer — Chief Financial Officer
Period of report
Jun 4, 2026
Accepted (ET)
Jun 8, 2026 · 7:39 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001488917
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2026 | M | 4,334 | $10.25 | A | 26,172 | D | |
| Common Stock | Jun 4, 2026 | M | 5,267 | $10.71 | A | 31,439 | D | |
| Common StockF1 | Jun 4, 2026 | S | 11,620 | $36.3355 | D | 19,819 | D | |
| Common StockF2 | Jun 4, 2026 | S | 181 | $37.114 | D | 19,638 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $10.25 | Jun 4, 2026 | M | 4,334 | D | — | Nov 10, 2033 | Common Stock | 4,334 | 2,166 | D |
| Employee Stock Option (right to buy)F3 | $10.71 | Jun 4, 2026 | M | 5,267 | D | — | Jun 30, 2033 | Common Stock | 5,267 | 2,633 | D |
Explanation of responses
- F1Reflects the weighted average price of 11,620 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 4, 2026 with sale prices ranging from $36.04 to $37.02 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Reflects the weighted average price of 181 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 4, 2026 with sale prices ranging from $37.055 to $37.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Scheduled to vest and become exercisable with respect to remaining shares on June 30, 2026.